000 01786 a2200481 4500
005 20250516192523.0
264 0 _c20140616
008 201406s 0 0 eng d
022 _a1530-6860
024 7 _a10.1096/fj.13-241893
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoeberl, Dwight D
245 0 0 _aAdjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.
_h[electronic resource]
260 _bFASEB journal : official publication of the Federation of American Societies for Experimental Biology
_cMay 2014
300 _a2171-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic beta-2 Receptor Agonists
_xtherapeutic use
650 0 4 _aAlbuterol
_xtherapeutic use
650 0 4 _aBiopsy
650 0 4 _aElectrocardiography
650 0 4 _aEnzyme Replacement Therapy
_xmethods
650 0 4 _aFemale
650 0 4 _aGlycogen Storage Disease Type II
_xdrug therapy
650 0 4 _aHand Strength
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMuscle, Skeletal
_xmetabolism
650 0 4 _aPilot Projects
650 0 4 _aQuadriceps Muscle
_xmetabolism
650 0 4 _aReceptor, IGF Type 2
_xmetabolism
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aWalking
700 1 _aAustin, Stephanie
700 1 _aCase, Laura E
700 1 _aSmith, Edward C
700 1 _aBuckley, Anne F
700 1 _aYoung, Sarah P
700 1 _aBali, Deeksha
700 1 _aKishnani, Priya S
773 0 _tFASEB journal : official publication of the Federation of American Societies for Experimental Biology
_gvol. 28
_gno. 5
_gp. 2171-6
856 4 0 _uhttps://doi.org/10.1096/fj.13-241893
_zAvailable from publisher's website
999 _c23466514
_d23466514